High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART. (Q43742382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Horváth A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Bánhegyi D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Bíró A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Ujhelyi E

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Veres A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Horváth L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Tarján V

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Romics L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Horváth I

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Tóth FD

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Füst G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

756-768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

Naturally occurring autoantibodies to cholesterol in humans

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Anti-cholesterol antibodies (ACHA) in patients with different atherosclerotic vascular diseases and healthy individuals. Characterization of human ACHA

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Hypertriglyceridemia in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

"Buffalo hump" in men with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Visceral abdominal-fat accumulation associated with use of indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Fat distribution and metabolic changes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Cholesterol sulphate-reactive autoantibodies are specifically increased in chronic chagasic human patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

The role of mononuclear phagocytes in HTLV-III/LAV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Anti-cardiolipin antibodies are associated with anti-endothelial cell antibodies but not with anti-beta 2 glycoprotein I antibodies in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Recognition of defined epitopes by affinity-purified anti-immunoglobulin fab autoantibodies isolated from HIV-infected humans

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Analysis of autoantibodies to T-cell receptors among HIV-infected individuals: epitope analysis and time course

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Influence of protease inhibitor therapy on lipoprotein metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

Plasma lipids in HIV-infected patients: a prospective study in 95 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2801%2980004-8

7 January 2021

10.1016/S0171-2985(01)80004-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11563675%20AND%20SRC:MED&resulttype=core&format=json